By the end of this year, investors will see what happens to global oil supplies when years of underinvestment come to fruition. Click here to read more.Read full newsRead More
Dyne Therapeutics, Inc. has enjoyed a recent bounce from good news from a rival, more than tripling in price. Click here to see our take on DYN stock.Read full newsRead More
Enbridge and TC Energy Corporation are two high-yield investment grade midstream businesses. Read more to find out which stock is a better buy.Read full newsRead More
Insteel Industries, Inc. (NYSE:NYSE:IIIN) Q1 2023 Earnings Conference Call January 19, 2022 10:00 AM ETCompany ParticipantsH.O.Read full newsRead More
Netflix press release(NFLX): Q4GAAP EPS of $0.12misses by $0.38.Revenue of $7.85B (+1.8% Y/Y) in-line.Shares +5.46%.Read full newsRead More
Nutex Health had a fluke in 2020 and 2021 with good revenue streams but has failed to capitalize on it. Click here for our view of NUTX stock and its prospects.Read full newsRead More
Richelieu Hardware Ltd. (OTCPK:RHUHF) Q4 2022 Earnings Conference Call January 19, 2023 2:30 PM ETCompany ParticipantsRichard Lord - President and Chief Executive OfficerAntoine Auclair -...Read full newsRead More
CVS recently announced its investment in Carbon Health, a cloud-based urgent and primary care technology platform. Click here to find out why the stock is a Buy.Read full newsRead More
Bright Health Group adopts a strategic approach to address the challenges faced by the industry. See why I recommend to buy BHG stock.Read full newsRead More
Inomin Mines Inc. (TSXV: MINE), (Read full newsRead More
TRU Precious Metals Corp. is pleased to announce the acquisition of 14 mineral claims at its Golden Rose Project in Central Newfoundland.Read full newsRead More
Alcoa Corporation (NYSE:NYSE:AA) Q4 2022 Earnings Conference Call January 18, 2023 5:00 PM ETCompany ParticipantsJames Dwyer - Vice President, Investor RelationsRoy Harvey - President and...Read full newsRead More
The following slide deck was published by Alcoa Corporation in conjunction with their 2022 Q4 earnings call.Read full newsRead More
Teva Pharmaceutical's undoing was its $40.5B deal to acquire Allergan's generic drug business in 2015. Read why TEVA's 56% run in the stock price makes it a Sell.Read full newsRead More
Kinder Morgan, Inc. (NYSE:NYSE:KMI) Q4 2022 Results Conference Call January 18, 2023 4:30 PM ETCompany ParticipantsRich Kinder - Executive ChairmanSteve Kean - CEOKim Dang - PresidentTom...Read full newsRead More
Alpha Metallurgical Resources represents a very favorable risk-reward at ~1.1X EV/EBITDA. Click here to read why AMR stock is a Buy.Read full newsRead More
CenterPoint Energy is positioned to deliver reasonably strong growth through the end of the decade. See why CNP looks a bit expensive relative to its peers.Read full newsRead More
Bristol Myers Squibb touted the launch of 9 new products in the U.S. While these products need more insurance coverage, read why I still rate BMY stock a Buy.Read full newsRead More
Relay Therapeutics discovers drugs using a novel computational approach. Though I like RLAY stock, see why I will wait for a correction before taking a call.Read full newsRead More
I see very bright earnings prospects for Enterprise Products Partners L.P. both in the near term and also long term. Click here to see my take on EPD stock.Read full newsRead More